Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected Adults

Patrick G. Clay, Marypeace Mcrae, Jean Pierre Laurent

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected Adults'. Together they form a unique fingerprint.

Medicine & Life Sciences